{"id":"W4400272226","doi":"10.1200/jco.2024.42.16_suppl.e21533","title":"Prospective real-world evidence for the use of immune-checkpoint inhibitors and BRAF-targeted therapy in advanced melanoma from a large Canadian cohort.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Credit Valley Hospital; Niagara Health System; University of Alberta; Princess Margaret Cancer Centre; University of Calgary; Health Sciences Centre; Ottawa Hospital; Dalhousie University; University of Toronto; Sunnybrook Health Science Centre; Queen's University; Cancer Care Ontario","funders":"","keywords":"Medicine; Melanoma; Oncology; Targeted therapy; Immune checkpoint; Cohort; Ipilimumab; Prospective cohort study; Internal medicine; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005182564,0.0005268488,0.0006265441,0.001270262,0.00174348,0.001456532,0.00146364,0.0008893958,0.003877534],"category_scores_gemma":[0.01689976,0.0004635953,0.001589636,0.004367042,0.0009008989,0.0004398597,0.00102881,0.0007133598,0.0002977035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0156085,"about_ca_system_score_gemma":0.03572132,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9501324,"about_ca_topic_score_gemma":0.9658774,"domain_scores_codex":[0.9957097,0.0008432862,0.0004409087,0.0006226752,0.001756198,0.0006271634],"domain_scores_gemma":[0.9778977,0.003356612,0.009416465,0.001420289,0.006110016,0.00179891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001186101,0.00005295063,0.9868434,0.0004272033,0.0007756743,0.00007991105,0.0002182249,0.0001265058,0.0001168695,0.0001547114,0.002803271,0.007215208],"study_design_scores_gemma":[0.0002575472,0.0001362742,0.9940853,0.0002565938,0.0007936346,0.0001120481,0.0002832636,0.0002100366,0.0000515458,0.00004296225,0.00374271,0.0000281272],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9240097,0.02043626,0.0004692436,0.002702373,0.000147333,0.0003929665,0.04387235,0.00003254442,0.007937191],"genre_scores_gemma":[0.9859667,0.003830796,0.0006688303,0.0008422717,0.00005738939,0.0001202887,0.007874211,0.00001111255,0.000628524],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04986757,"threshold_uncertainty_score":0.1132482,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1046105215655982,"score_gpt":0.4095387828409206,"score_spread":0.3049282612753224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}